Independent
Tenure on this board
11.4 yrs
Also a director at
Lucid Diagnostics Inc (LUCD)
2 nominees · 3 ballot items.
Elect two Class A directors; approve amendments to the Employee Stock Purchase Plan to increase authorized shares and raise the evergreen annual increase limit; and ratify CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for 2026.
Elect two members of the Company’s Board of Directors (Class A) — Ronald M. Sparks and Timothy E. Baxter — to hold office until the third succeeding annual meeting.
Approve amendments to the Employee Stock Purchase Plan to increase authorized shares by 200,000 (from 15,774 to 215,774) and raise the annual evergreen increase limit from 5,556 to 500,000 shares.
This management proposal requests shareholder approval to amend the Company’s Employee Stock Purchase Plan (ESPP) by increasing the number of shares available for employee purchases from 15,774 to 215,774 and by raising the annual cap on the plan’s automatic (“evergreen”) yearly increases from 5,556 shares to up to 500,000 shares. Management and the Board frame the change as necessary to maintain the ESPP as an effective attraction, retention, and employee-alignment tool given current participation levels and the limited remaining share pool. The proxy explains the ESPP mechanics (six-month offering periods, 85% purchase price discount, eligibility rules, and Section 423 qualification intent) and notes executives generally are eligible to participate unless excluded. The amendment would immediately make 215,774 shares available, and thereafter allow annual increases each January 1 through January 1, 2031 equal to the lesser of 2% of outstanding shares at year-end or 500,000 shares, subject to the Board’s discretion to reduce or suspend an annual increase. From a governance and shareholder-value perspective, the proposal increases potential dilution materially relative to the current 15,774-share pool, particularly because the evergreen provision can add up to 500,000 shares per year (subject to the 2% cap), so shareholders should consider the potential long-term dilution versus the compensation and retention benefits. The Board discloses that executive officers may participate and that benefits to be received are not presently determinable, and it recommends a vote FOR on the basis that continued employee equity participation aligns employee interests with stockholders and supports the Company’s compensation strategy. The proposal is non-routine (so broker non-votes may occur) and requires majority approval of shares present and entitled to vote. Analysts evaluating this proposal should weigh the dilution and evergreen mechanics, the stated near-term need for shares to sustain the ESPP, the disclosed eligibility of executives, and the typical market practice for ESPP sizing and discount levels when forming a view on shareholder economic impact and governance appropriateness.
Ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Two Seas Capital LP | 6.35% | 461,539 | $5M |
| 2 | FIRST MANHATTAN CO. LLC. | 0.33% | 23,805 | $242K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.14% | 10,237 | $104K |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 0.08% | 5,917 | $60K |
| 5 | VANGUARD FIDUCIARY TRUST CO | 0.07% | 5,429 | $55K |
| 6 | BlackRock, Inc. | 0.03% | 2,416 | $25K |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.02% | 1,540 | $16K |
| 8 | Tower Research Capital LLC (TRC | 0.01% | 622 | $6K |
| 9 | MORGAN STANLEY | 0.00% | 165 | $2K |
| 10 | CWM, LLC | 0.00% | 157 | $2K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.